Herspiegel completed the acquisition of Decisive Consulting.

Herspiegel, a provider of pharmaceutical and biotech commercialization services, completed the acquisition of Decisive Consulting, a UK-based boutique consulting firm specializing in market access, pricing strategy and evidence-driven commercialization for the pharmaceutical, biotech, and health-tech sector. Financial terms were not disclosed. "The addition of Decisive Consulting further strengthens our ability to unlock asset value and improve patient access to life-changing therapies. Together, we offer the full spectrum of global market access expertise—from early evidence planning through successful launch and beyond," Brent Herspiegel, Herspiegel CEO.